Clinical impact of MYD88 mutations in chronic lymphocytic leukemia

Blood. 2016 Mar 24;127(12):1611-3. doi: 10.1182/blood-2015-10-678490. Epub 2016 Feb 4.

Authors

Alejandra Martínez-Trillos¹, Alba Navarro², Marta Aymerich³, Julio Delgado³, Armando López-Guillermo³, Elias Campo³, Neus Villamor³

Affiliations

¹ Hematopathology Unit and Department of Hematology, Hospital Clínic, Barcelona, Spain; and.
² Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
³ Hematopathology Unit and Department of Hematology, Hospital Clínic, Barcelona, Spain; and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

PMID: 26847246
DOI: 10.1182/blood-2015-10-678490

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers, Tumor / genetics*
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
Male
Myeloid Differentiation Factor 88 / genetics*

Substances

Biomarkers, Tumor
Myeloid Differentiation Factor 88